Publication | Open Access

Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification

Medicinal ChemistryDrug RepositioningDrug TargetSystematic DrugNovel Cyp1b1 InhibitorMedicineRational Drug DesignPharmacotherapyDrug DevelopmentSystems BiologyPharmacologyDrug DiscoveryStructure-based Virtual ScreeningDrug Resistance